Literature DB >> 24875098

Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancer.

James C Fleet1.   

Abstract

Colorectal cancer is a heterogeneous disease that is one of the major causes of cancer death in the U.S. There is evidence that lifestyle factors like diet can modulate the course of this disease. Demonstrating the benefit and mechanism of action of dietary interventions against colon cancer will require studies in preclinical models. Many mouse models have been developed to study colon cancer but no single model can reflect all types of colon cancer in terms of molecular etiology. In addition, many models develop only low-grade cancers and are confounded by development of the disease outside of the colon. This review will discuss how mice can be used to model human colon cancer and it will describe a variety of new mouse models that develop colon-restricted cancer as well as more advanced phenotypes for studies of late-state disease.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  animal; chemoprevention; mutation; preclinical; sporadic

Mesh:

Year:  2014        PMID: 24875098      PMCID: PMC4121636          DOI: 10.1152/ajpgi.00019.2014

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  132 in total

1.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria.

Authors:  Malin E V Johansson; Mia Phillipson; Joel Petersson; Anna Velcich; Lena Holm; Gunnar C Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

Review 2.  Pathology of rodent models of intestinal cancer: progress report and recommendations.

Authors:  Mary Kay Washington; Anne E Powell; Ruth Sullivan; John P Sundberg; Nicholas Wright; Robert J Coffey; William F Dove
Journal:  Gastroenterology       Date:  2013-02-12       Impact factor: 22.682

Review 3.  The influence of diet on the gut microbiota.

Authors:  Karen P Scott; Silvia W Gratz; Paul O Sheridan; Harry J Flint; Sylvia H Duncan
Journal:  Pharmacol Res       Date:  2012-11-09       Impact factor: 7.658

4.  Impact of deleterious passenger mutations on cancer progression.

Authors:  Christopher D McFarland; Kirill S Korolev; Gregory V Kryukov; Shamil R Sunyaev; Leonid A Mirny
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

Review 5.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

6.  Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers.

Authors:  Rebecca J Leary; Jimmy C Lin; Jordan Cummins; Simina Boca; Laura D Wood; D Williams Parsons; Siân Jones; Tobias Sjöblom; Ben-Ho Park; Ramon Parsons; Joseph Willis; Dawn Dawson; James K V Willson; Tatiana Nikolskaya; Yuri Nikolsky; Levy Kopelovich; Nick Papadopoulos; Len A Pennacchio; Tian-Li Wang; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

7.  Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation.

Authors:  Victoria Marsh; Douglas J Winton; Geraint T Williams; Nicole Dubois; Andreas Trumpp; Owen J Sansom; Alan R Clarke
Journal:  Nat Genet       Date:  2008-11-16       Impact factor: 38.330

8.  Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis.

Authors:  Mark Schliekelman; Dale O Cowley; Ryan O'Quinn; Trudy G Oliver; Lucy Lu; E D Salmon; Terry Van Dyke
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

9.  Monotonous diets protect against acute colitis in mice: epidemiologic and therapeutic implications.

Authors:  Dorottya Nagy-Szakal; Sabina A V Mir; Matthew C Ross; Nina Tatevian; Joseph F Petrosino; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-05       Impact factor: 2.839

10.  Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines.

Authors:  Sanjib Chowdhury; Melanie Ongchin; Elizabeth Sharratt; Ivan Dominguez; Jing Wang; Michael G Brattain; Ashwani Rajput
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more
  3 in total

1.  An Inducible, Large-Intestine-Specific Transgenic Mouse Model for Colitis and Colitis-Induced Colon Cancer Research.

Authors:  Fa Wang; Robert L Johnson; Paul W Snyder; Marsha L DeSmet; James C Fleet
Journal:  Dig Dis Sci       Date:  2015-12-02       Impact factor: 3.199

2.  Olaparib, Monotherapy or with Ionizing Radiation, Exacerbates DNA Damage in Normal Tissues: Insights from a New p21 Reporter Mouse.

Authors:  Michael McMahon; Tania G Frangova; Colin J Henderson; C Roland Wolf
Journal:  Mol Cancer Res       Date:  2016-09-07       Impact factor: 5.852

3.  Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B.

Authors:  Jie Zheng; Hye Lim Lee; Young Wan Ham; Ho Sueb Song; Min Jong Song; Jin Tae Hong
Journal:  Oncotarget       Date:  2015-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.